Nephrocare Health Services Limited has officially informed BSE Limited and National Stock Exchange of India Limited about the appointment of its Compliance Officer under SEBI regulations. The company submitted the notification on December 22, 2025, confirming the appointment details and compliance with regulatory requirements.

Compliance Officer Appointment Details

The company appointed Kishore Kathri as Company Secretary and Compliance Officer effective July 16, 2025. The appointment was made in accordance with Regulation 6(1) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Professional Background and Qualifications

Kishore Kathri brings substantial expertise to his role at Nephrocare Health Services Limited. He is responsible for ensuring managerial, secretarial, and regulatory compliances of the company. Kathri holds an associate membership with the Institute of Company Secretaries of India and possesses comprehensive educational qualifications.

His academic credentials include a bachelor's degree in commerce and law, along with a master's degree in corporate and securities laws, all obtained from Osmania University, Hyderabad. This educational foundation provides him with the necessary knowledge base for his compliance responsibilities.

Professional Experience

Kathri has accumulated over 12 years of professional experience across various domains critical to his current role. His expertise spans:

• Corporate governance
• Regulatory compliance
• Board administration
• Contract drafting
• Legal advisory services

His experience encompasses work with listed companies in both manufacturing and services sectors. Prior to joining Nephrocare Health Services Limited, Kathri was associated with several notable organizations including Birla Nu Limited (formerly HIL Limited), GOCL Corporation Limited, Vishnu Chemicals Limited, Granules India Limited, and Corpus Software Private Limited.

Regulatory Compliance

The appointment notification was submitted under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Para A of Part A of Schedule III to the said Regulations. This ensures full compliance with regulatory requirements for changes in Key Managerial Personnel.

The company continues to maintain its compliance obligations following its listing on stock exchanges, with Kathri serving as the designated Compliance Officer to oversee adherence to all applicable regulations and requirements.

Nephro Care has made a significant claim about its market position, stating that it is only the third dialysis company worldwide to achieve public listing status. This milestone underscores the company's unique position in the global dialysis sector and highlights the relatively limited number of publicly traded companies in this specialized healthcare segment.

Global Market Position

Nephrocare Health claims to be only the third dialysis company worldwide to achieve public listing status, highlighting its unique market position in the global dialysis sector. This assertion positions it within an exclusive group of publicly traded entities in the dialysis industry. The claim suggests that the dialysis sector has relatively few companies that have achieved public market status, making Nephrocare's listing a notable achievement in the healthcare space.

Strategic Growth Objectives

Nephro Care maintains an ambitious growth strategy, targeting a compound annual growth rate (CAGR) between 25.00% and 30.00%. This growth target reflects the company's confidence in leveraging its unique market position to expand operations and capture market opportunities in the healthcare sector.

Industry Significance

The combination of being among the few listed dialysis companies globally and setting aggressive growth targets demonstrates Nephrocare's strategic positioning in the healthcare market. The company's public listing status provides it with access to capital markets, potentially supporting its expansion plans and growth objectives in the specialized dialysis segment.